Toggle navigation
Home
Search
Services
Blog
Contact
About
Medications Development for Stimulant Dependence
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Amplifying provider impact on patient engagement with an EHR- integrated digital diabetes prevention program
Discovery and Characterization of Natural Product Systems
Anxiety and Alcohol Drinking in a Genetic Animal Model of Alcoholism
Control of Muscle Tone by the Nucleus Magnocellularis
Recently added grants:
Biology of human cytotoxic CD4 T cells (CD4-CTLs) in viral infections
Social Epidemiology of COVID-19
STING-Dependent Pathways Restraining Severe Schistosome Immunopathology
Objective measures of adherence for later-stage ART failure in resource limited settings
Characterizing the negative signaling in dendritic cells and macrophages to attenuate inflammation and bone destruction in Rheumatoid arthritis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research and Development Contracts (N01)
Project #
N01DA78863-4-0-1
Application #
7584775
Study Section
Project Start
2007-04-23
Project End
2012-04-22
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 DA
Medications Development for Stimulant Dependence
Galloway, Gantt P. / California Pacific Medical Center Research Institute
$1,138,487
NIH 2007
N01 DA
Galloway, Gantt P. /
NIH 2007
N01 DA
Medications Development for Stimulant Dependence
/
Comments
Be the first to comment on this grant